Opioid-Induced Constipation in Oncological Patients: New Strategies of Management

por Mesía, Ricard, Virizuela Echaburu, Juan Antonio, Gómez, Jose, Sauri, Tamara, Serrano, Gloria, Pujol, Eduardo
Publicado 2019

Paraneoplastic Limbic Encephalitis in a Male with Squamous Cell Carcinoma of the Lung

por Sauri, Tamara, Izquierdo, Àngel, Ramió-Torrentà, LLuis, Sanchez-Montañez, Àngel, Bosch-Barrera, Joaquim, Porta, Rut
Publicado 2015

New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy

por Mauro, Ezequiel, Ferrer-Fàbrega, Joana, Sauri, Tamara, Soler, Alexandre, Cobo, Amparo, Burrel, Marta, Iserte, Gemma, Forner, Alejandro
Publicado 2023

Mutational Status of SMAD4 and FBXW7 Affects Clinical Outcome in TP53–Mutated Metastatic Colorectal Cancer

por Lahoz, Sara, Rodríguez, Adela, Fernández, Laia, Gorría, Teresa, Moreno, Reinaldo, Esposito, Francis, Oliveres, Helena, Albiol, Santiago, Saurí, Tamara, Pesantez, David, Riu, Gisela, Cuatrecasas, Miriam, Jares, Pedro, Pedrosa, Leire, Pineda, Estela, Postigo, Antonio, Castells, Antoni, Prat, Aleix, Maurel, Joan, Camps, Jordi
Publicado 2022

Analysis of mutant allele fractions in driver genes in colorectal cancer – biological and clinical insights

por Dienstmann, Rodrigo, Elez, Elena, Argiles, Guillem, Matos, Ignacio, Sanz‐Garcia, Enrique, Ortiz, Carolina, Macarulla, Teresa, Capdevila, Jaume, Alsina, Maria, Sauri, Tamara, Verdaguer, Helena, Vilaro, Marta, Ruiz‐Pace, Fiorella, Viaplana, Cristina, Garcia, Ariadna, Landolfi, Stefania, Palmer, Hector G., Nuciforo, Paolo, Rodon, Jordi, Vivancos, Ana, Tabernero, Josep
Publicado 2017

Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-bas...

por García-Corbacho, Javier, Indacochea, Alberto, González Navarro, Azucena E., Victoria, Iván, Moreno, Débora, Pesántez, David, Angelats, Laura, Modrego-Sanchez, Andrea, Sanfeliu, Esther, Castillo, Oleguer, Blasco, Paula, Mezquita, Laura, Viñolas, Nuria, Nogué, Miquel, Galván, Patricia, Adamo, Barbara, Basté, Neus, Sauri, Tamara, Juan, Manel, Prat, Aleix, Schettini, Francesco
Publicado 2023

Correction to: Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospectiv...

por García-Corbacho, Javier, Indacochea, Alberto, González Navarro, Azucena E., Victoria, Iván, Moreno, Débora, Pesántez, David, Angelats, Laura, Modrego-Sanchez, Andrea, Sanfeliu, Esther, Castillo, Oleguer, Blasco, Paula, Mezquita, Laura, Viñolas, Nuria, Nogué, Miquel, Galván, Patricia, Adamo, Barbara, Basté, Neus, Sauri, Tamara, Juan, Manel, Prat, Aleix, Schettini, Francesco
Publicado 2023

Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors

por Auclin, Edouard, Vuagnat, Perrine, Smolenschi, Cristina, Taieb, Julien, Adeva, Jorge, Nebot-Bral, Laetitia, Garcia de Herreros, Marta, Vidal Tocino, Rosario, Longo-Muñoz, Federico, El Dakdouki, Yola, Martín-Romano, Patricia, Gaba, Lydia, Saurí, Tamara, Oliveres, Helena, Castañón, Eduardo, Garcia-Carbonero, Rocio, Besse, Benjamin, Massard, Christophe, Mezquita, Laura, Hollebecque, Antoine
Publicado 2021

The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)

por Bendell, Johanna C., Sauri, Tamara, Gracián, Antonio Cubillo, Alvarez, Rafael, López‐López, Carlos, García‐Alfonso, Pilar, Hussein, Maen, Miron, Maria‐Luisa Limon, Cervantes, Andrés, Montagut, Clara, Vivas, Cristina Santos, Bessudo, Alberto, Plezia, Patricia, Moons, Veerle, Andel, Johannes, Bennouna, Jaafar, van der Westhuizen, Andre, Samuel, Leslie, Rossomanno, Simona, Boetsch, Christophe, Lahr, Angelika, Franjkovic, Izolda, Heil, Florian, Lechner, Katharina, Krieter, Oliver, Hurwitz, Herbert
Publicado 2019

ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer

por Griguolo, Gaia, Brasó-Maristany, Fara, González-Farré, Blanca, Pascual, Tomás, Chic, Núria, Saurí, Tamara, Kates, Ronald, Gluz, Oleg, Martínez, Débora, Paré, Laia, Tsvetkova, Vassilena, Pesantez, David, Vidal, Maria, Adamo, Barbara, Muñoz, Montserrat, Galván, Patricia, Barberá, Laura, Cuatrecasas, Miriam, Christgen, Mathias, Kreipe, Hans, Monge-Escartín, Inés, Villagrasa, Patricia, Soy, Dolors, Giarratano, Tommaso, Dieci, Maria Vittoria, Conte, Pierfranco, Harbeck, Nadia, Guarneri, Valentina, Prat, Aleix
Publicado 2020

External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry

por Jimenez-Fonseca, Paula, Carmona-Bayonas, Alberto, Martinez-Torron, Alba, Alsina, Maria, Custodio, Ana, Serra, Olbia, Cacho Lavin, Diego, Limón, María Luisa, Sauri, Tamara, López, Flora, Visa, Laura, Granja, Mónica, Martínez Lago, Nieves, Arrazubi, Virginia, Vidal Tocino, Rosario, Hernandez, Raquel, Aguado, Gema, Cano, Juana María, Martín Carnicero, Alfonso, Mangas, Monserrat, Pimentel, Paola, Fernández Montes, Ana, Macias Declara, Ismael, Longo, Federico, Ramchandani, Avinash, Martín Richard, Marta, Hurtado, Alicia, Azkarate, Aitor, Hernández Pérez, Carolina, Serrano, Raquel, Gallego, Javier
Publicado 2021

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

por Jimenez-Fonseca, Paula, Carmona-Bayonas, Alberto, Martínez de Castro, Eva, Custodio, Ana, Pericay Pijaume, Carles, Hernandez, Raquel, Aguado, Gema, Castro Unanua, Natalia, Cano, Juana María, López, Flora, Garrido, Marcelo, Fernández Montes, Ana, Visa, Laura, Sánchez Cánovas, Manuel, Limón, María Luisa, Martínez Lago, Nieves, Pimentel, Paola, Hurtado, Alicia, Azkárate, Aitor, Longo, Federico, Diez, Marc, Arias-Martinez, Aranzazu, Sauri, Tamara, Martín Carnicero, Alfonso, Mangas, Monserrat, Martín Richard, Marta, Granja, Mónica, Ramchandani, Avinash, Hernández Pérez, Carolina, Cerdá, Paula, Gil-Negrete, Aitziber, Calvo, Mariona, Vidal Tocino, Rosario, Gallego, Javier
Publicado 2020

The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

por Jimenez-Fonseca, Paula, Foy, Victoria, Raby, Sophie, Carmona-Bayonas, Alberto, Macía-Rivas, Lola, Arrazubi, Virginia, Cacho Lavin, Diego, Hernandez San Gil, Raquel, Custodio, Ana, Cano, Juana María, Fernández Montes, Ana, Mirallas, Oriol, Macias Declara, Ismael, Vidal Tocino, Rosario, Visa, Laura, Limón, María Luisa, Pimentel, Paola, Martínez Lago, Nieves, Sauri, Tamara, Martín Richard, Marta, Mangas, Monserrat, Gil Raga, Mireia, Calvo, Aitana, Reguera, Pablo, Granja, Mónica, Martín Carnicero, Alfonso, Hernández Pérez, Carolina, Cerdá, Paula, Gomez Gonzalez, Lucía, Garcia Navalon, Francisco, Pacheco Barcia, Vilma, Gutierrez Abad, David, Ruiz Martín, Maribel, Weaver, Jamie, Mansoor, Wasat, Gallego, Javier
Publicado 2023